mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.25 |
0.02 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |